
Gujarat Themis Biosyn Ltd. - Investor Relations & Filings
Key figures FY2026
| Total Revenues | INR 1.66B | per the Interim / Quarterly Report filed 2026-05-25 |
|---|---|---|
| Net Income | INR 466.81M | per the Interim / Quarterly Report filed 2026-05-25 |
| Total Assets | INR 5.03B | per the Interim / Quarterly Report filed 2026-05-25 |
| Total Equity | INR 2.88B | per the Interim / Quarterly Report filed 2026-05-25 |
| Cash from Ops | INR 487.77M | per the Interim / Quarterly Report filed 2026-05-25 |
As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.
Gujarat Themis Biosyn Ltd. specializes in the manufacture of active pharmaceutical ingredients and intermediates through advanced fermentation technology. The company focuses on the production of fermentation-based bulk drugs, with a primary product portfolio that includes Rifampicin intermediates and Lovastatin. Utilizing large-scale fermentation processes, the organization engages in strain improvement and media optimization to enhance yield and efficiency. The company operates a dedicated manufacturing facility equipped for complex biotechnological processes. Through technical collaborations with international entities, it has integrated specialized expertise in fermentation science to support the development of high-purity chemical compounds. Its operations are centered on providing essential building blocks for various therapeutic applications, maintaining a focus on technical precision and process-driven manufacturing excellence.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Shareholders meeting | 2026-07-10 | English | |
| Shareholders meeting | 2026-07-10 | English | |
| Please refer to the attachment. | 2026-07-10 | English | |
| Please refer to the attachment. | 2026-07-10 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-07-10 | English | |
| Please refer to attached Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018. | 2026-07-10 | English |
Browse filings by year
8 yearsFinancials
We couldn't load the financials
No data available yet
We have extracted financials for Gujarat Themis Biosyn Ltd., but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available - coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
| 4D Pharma PLC | DDDD | GB | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
Gujarat Themis Biosyn Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62621/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62621 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing - metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62621 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62621 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62621}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Gujarat Themis Biosyn Ltd. (id: 62621)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.